This new position paper describes and analyses the current and potential applications and value creation of Generative AI for pharmaceutical companies.
News
« High-performance Market Access Brand Plans require method, rigor and pragmatism » Our new publication on how to build...
This new paper highlights our analyses on:
Based on the analysis of the most recent data and trends (gathered in The Global Pharma Market...